Crossmark Global Holdings, Inc. Pfizer Inc Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 75,272 shares of PFE stock, worth $2.01 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

75,272

Previous 78,100 3.62%

Holding current value

$2.01 Million

Previous $2.19 Million 0.32%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$27.7 - $31.39 $78,335 - $88,770	-2,828 Reduced 3.62%	75,272 $2.18 Million
Q2 2024 Jul 29, 2024	SELL	$25.26 - $29.6 $10,937 - $12,816	-433 Reduced 0.55%	78,100 $2.19 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $8,543 - $9,810	-330 Reduced 0.42%	78,533 $2.18 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $28,925 - $37,571	1,107 Added 1.42%	78,863 $2.27 Million
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $3.08 Million - $3.61 Million	-96,131 Reduced 55.28%	77,756 $2.58 Million
Q2 2023 Jul 31, 2023	BUY	$36.12 - $41.79 $667,280 - $772,028	18,474 Added 11.89%	173,887 $6.27 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $100,326 - $130,610	2,547 Added 1.67%	155,413 $6.34 Million
Q4 2022 Jan 19, 2023	SELL	$41.75 - $54.5 $23,881 - $31,174	-572 Reduced 0.37%	152,866 $7.83 Million
Q3 2022 Nov 01, 2022	SELL	$43.76 - $53.42 $54,787 - $66,881	-1,252 Reduced 0.81%	153,438 $6.71 Million
Q2 2022 Jul 29, 2022	SELL	$46.53 - $55.17 $9,910 - $11,751	-213 Reduced 0.14%	154,690 $8.11 Million
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $4.53 Million - $5.61 Million	98,959 Added 176.89%	154,903 $8.02 Million
Q4 2021 Jan 10, 2022	SELL	$41.32 - $61.25 $108,712 - $161,148	-2,631 Reduced 4.49%	55,944 $3.3 Million
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $222,272 - $285,528	-5,663 Reduced 8.82%	58,575 $2.52 Million
Q3 2021 Oct 13, 2021	BUY	$39.25 - $50.42 $296,808 - $381,276	7,562 Added 13.34%	64,238 $1.6 Million
Q2 2021 Jul 21, 2021	SELL	$35.91 - $40.68 $5.16 Million - $5.85 Million	-143,796 Reduced 71.73%	56,676 $2.22 Million
Q1 2021 Apr 15, 2021	BUY	$33.49 - $37.77 $4.17 Million - $4.71 Million	124,601 Added 164.23%	200,472 $7.26 Million
Q4 2020 Jan 14, 2021	SELL	$33.47 - $42.56 $6.36 Million - $8.09 Million	-190,091 Reduced 71.47%	75,871 $2.79 Million
Q3 2020 Oct 08, 2020	SELL	$31.75 - $37.25 $474,091 - $556,217	-14,932 Reduced 5.32%	265,962 $9.76 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $324,844 - $394,083	-10,785 Reduced 3.7%	280,894 $9.19 Million
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $96,848 - $138,375	-3,583 Reduced 1.21%	291,679 $9.03 Million
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $82,563 - $93,698	-2,508 Reduced 0.84%	295,262 $11.6 Million
Q3 2019 Oct 09, 2019	SELL	$32.49 - $42.13 $2.53 Million - $3.28 Million	-77,751 Reduced 20.7%	297,770 $10.7 Million
Q2 2019 Jul 09, 2019	BUY	$36.98 - $41.52 $351,901 - $395,104	9,516 Added 2.6%	375,521 $16.3 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $50,550 - $55,537	-1,348 Reduced 0.37%	366,005 $15.5 Million
Q4 2018 Jan 31, 2019	BUY	$38.47 - $43.86 $652,258 - $743,646	16,955 Added 4.84%	367,353 $16 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $87,450 - $106,071	-2,537 Reduced 0.72%	350,398 $15.4 Million
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $563,496 - $600,743	-17,086 Reduced 4.62%	352,935 $12.8 Million
Q1 2018 Apr 16, 2018	SELL	$31.91 - $37.02 $201,990 - $234,336	-6,330 Reduced 1.68%	370,021 $13.1 Million
Q4 2017 Feb 05, 2018	BUY	$33.26 - $35.29 $45,998 - $48,806	1,383 Added 0.37%	376,351 $13.6 Million
Q3 2016 Oct 25, 2017	BUY	N/A	374,968	374,968 $13.4 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Pfizer Inc Transaction History